Uroplasty, Inc. (UPI) Posts Q4 Loss of $0.05

Uroplasty, Inc. (NASDAQ: UPI) reported Q4 EPS of ($0.05), $0.03 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $5.42 million.

For earnings history and earnings-related data on Uroplasty, Inc. (UPI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nayax Ltd. (NYAX) Misses Q2 EPS by 39c; reaffirms guidance
• AMMO Inc. (POWW) Tops Q1 EPS by 3c
• Niu Technologies (NIU) Reports Q2 Loss of $0.19